Clinical Trial

A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study (IP2015CS05) is a randomised, double-blind, placebo-controlled, 4-way cross-over trial studying the efficacy and safety of single dose administration of pudafensine in vulvodynia (provoked vestibulodynia) patients.
Trial Details
NCT Number NCT07391241
Lead Sponsor Initiator Pharma
Conditions Vulvodynia
Enrollment 24 participants
Start Date 2025-12-17
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-05